Sign inJoin waitlistJoin the waitlist

RD

Robert Dillman

Hematology & Oncology

Credentials: ·

Research

Phase II study of belagenpumatucel-L, a transforming growth factor beta-2 antisense gene-modified allogeneic tumor cell vaccine in non-small-cell lung cancer
Journal of Clinical Oncology · 2006 · 284 citations
Single-agent monoclonal antibody efficacy in bulky non-Hodgkin's lymphoma: results of a phase II trial of rituximab
Journal of Clinical Oncology · 1999 · 232 citations
A comparative study of two different doses of cytarabine for acute myeloid leukemia: a phase III trial of Cancer and Leukemia Group B
Blood · 1991 · First of 10 authors · 148 citations

NB
Neil Barth
28 papers
Louis Vandermolen
12 papers
SH
Samuel Halpern
12 papers
KM
Khosrow Mahdavi
9 papers
SS
Stephen Seagren
8 papers
CD
Christopher Duma
6 papers
EM
Edward Mcclay
6 papers
RO
Robert Oldham
6 papers
LS
Lee Schwartzberg
5 papers
RH
Russell Hafer
4 papers
Daniela Bota
3 papers
DT
Datchen Tai
3 papers